Literature DB >> 26131241

Correlation between serum cystatin C level and elderly hypertensive patients combined coronary heart disease.

Ying Wang2, Xianming Su2, Wei Zhang2, Wei Yang2, Ying Wang2, Yajun He3.   

Abstract

OBJECTIVES: To explore the correlation between serum cystatin C level and elderly hypertension with coronary heart disease patients.
METHODS: 500 hypertensive patients combined coronary heart disease were selected by coronary angiography. 321 of them were elderly patients with hypertension (male 204, female 117), and 400 of them were elderly patients with coronary heart disease (male 257, female 143), The serum cystatin C level of all patients were detected by immunoturbidimetry, and analyzed the correlation between the serum cystatin C level and different degree of blood pressure and the degree of coronary artery stenosis in elderly patients.
RESULTS: The serum cystatin C level was closely related with the blood pressure and the degree of the coronary artery stenosis. The higher the blood pressure level and the more serious the coronary artery stenosis, the higher the serum cystatin C level; The serum cystatin C level of hypertensive patients with coronary heart disease patients (Group D) were markedly higher than the level of the patients without hypertension and coronary heart disease patients (Group A), and the level of the patients with coronary heart disease (Group B) and the hypertension group (Group C) (P < 0.05).
CONCLUSION: The serum cystatin C level of elderly patients with hypertension and coronary heart disease were closely related with the degree of blood pressure and coronary arteries stenosis. The serum cystatin C maybe a predictor of disease severity in elderly hypertensive patients with coronary heart disease.

Entities:  

Keywords:  Cystatin C; coronary artery disease; correlation; elderly patients; hypertension

Year:  2015        PMID: 26131241      PMCID: PMC4483934     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  6 in total

Review 1.  Inflammatory pathways in atherosclerosis and acute coronary syndromes.

Authors:  J Plutzky
Journal:  Am J Cardiol       Date:  2001-10-18       Impact factor: 2.778

2.  Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.

Authors:  Wolfgang Koenig; Dorothee Twardella; Hermann Brenner; Dietrich Rothenbacher
Journal:  Clin Chem       Date:  2004-11-24       Impact factor: 8.327

3.  Cystatin C as a marker of renal function in kidney transplant patients.

Authors:  A Mendiluce; J Bustamante; D Martin; M Santos; R Bustamante; P Pascual; N S Jabary; A Castañeda; M A F Muñoz
Journal:  Transplant Proc       Date:  2005-11       Impact factor: 1.066

4.  Clinical prognostic significance of plasma cystatin C levels among patients with acute coronary syndrome.

Authors:  Changjiang Ge; Fang Ren; Shuzheng Lu; Fengqing Ji; Xin Chen; Xiaofan Wu
Journal:  Clin Cardiol       Date:  2009-11       Impact factor: 2.882

5.  Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.

Authors:  Anjali Ganda; Martin Magnusson; Laurent Yvan-Charvet; Bo Hedblad; Gunnar Engström; Ding Ai; Thomas J Wang; Robert E Gerszten; Olle Melander; Alan R Tall
Journal:  Circulation       Date:  2013-02-01       Impact factor: 29.690

6.  Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis.

Authors:  Bryan Kestenbaum; Kyle D Rudser; Ian H de Boer; Carmen A Peralta; Linda F Fried; Michael G Shlipak; Walter Palmas; Catherine Stehman-Breen; David S Siscovick
Journal:  Ann Intern Med       Date:  2008-04-01       Impact factor: 25.391

  6 in total
  2 in total

1.  Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Zheng Tan; Li Li; Yi Ma; Xuebin Geng
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

2.  Prognostic ability of cystatin C and homocysteine plasma levels for long-term outcomes in very old acute myocardial infarction patients.

Authors:  Zhenhong Fu; Xia Yang; Mingzhi Shen; Hao Xue; Geng Qian; Feng Cao; Jun Guo; Wei Dong; Yundai Chen
Journal:  Clin Interv Aging       Date:  2018-07-03       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.